KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medtronic (MDT) EPS (Basic) (2016 - 2026)

Medtronic's EPS (Basic) history spans 13 years, with the latest figure at $0.89 for Q1 2026.

  • For Q1 2026, EPS (Basic) fell 11.88% year-over-year to $0.89; the TTM value through Jan 2026 reached $3.6, up 8.76%, while the annual FY2025 figure was $3.63, 31.05% up from the prior year.
  • EPS (Basic) for Q1 2026 was $0.89 at Medtronic, down from $1.07 in the prior quarter.
  • Across five years, EPS (Basic) topped out at $1.11 in Q2 2022 and bottomed at $0.32 in Q4 2022.
  • The 5-year median for EPS (Basic) is $0.89 (2026), against an average of $0.84.
  • The largest annual shift saw EPS (Basic) tumbled 67.01% in 2022 before it skyrocketed 115.62% in 2023.
  • A 5-year view of EPS (Basic) shows it stood at $0.32 in 2022, then soared by 115.63% to $0.69 in 2023, then soared by 43.48% to $0.99 in 2024, then rose by 8.08% to $1.07 in 2025, then decreased by 16.82% to $0.89 in 2026.
  • Per Business Quant, the three most recent readings for MDT's EPS (Basic) are $0.89 (Q1 2026), $1.07 (Q4 2025), and $0.81 (Q3 2025).